Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain

Brain Research

Volumn 849, Issue 1-2, 1999, Pages 85-96

  Tsukada, Hideo ^a   Nishiyama, Shingo ^a   Kakiuchi, Takeharu ^a   Ohba, Hiroyuki ^a   Sato, Kengo ^a   Harada, Norihiro ^a   Nakanishi, Satoshi ^b  

^a CENTRAL RESEARCH LABORATORY   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Dopamine D2 receptor; Dopamine transporter; Isoflurane; Microdialysis; Monkey brain; Positron emission tomography

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; COCAINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; ISOFLURANE; RACLOPRIDE; VANOXERINE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICRODIALYSIS; MONKEY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANESTHESIA, INHALATION; ANIMALS; BRAIN; CARBON RADIOISOTOPES; CARRIER PROTEINS; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; ISOFLURANE; KINETICS; MACACA MULATTA; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICRODIALYSIS; NERVE TISSUE PROTEINS; PIPERAZINES; RECEPTORS, DOPAMINE D2; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; WAKEFULNESS;

EID: 0032734511     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02018-1     Document Type: Article

References (56)

1. Baumann M.H., Char G.U., DeCosta B.R., Rice K.C., Rothman R.B. GBR12909 attenuate cocaine-induced activation of mesolimbic dopamine neurons in the rat. J. Pharmacol. Exp. Ther. 271:1994;1216-1222.
2. Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A. 86:1989;9030-9033.
3. Carboni E., Imperato A., Perezzani L., DiChiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience. 28:1989;653-661.
4. Carlsson M., Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. TINS. 13:1990;272-276.
5. 11C ]raclopride binding with continuous infusion J. Cereb. Blood Flow Metab. 17:1997;437-447.
6. Cepeda C., Buchwald N.A., Levine M.S. Neuromodulatory actions of dopamine in the neostriatum are depend upon the excitatory amino acid receptor subtypes activated. Proc. Natl. Acad. Sci. U.S.A. 90:1993;9576-9580.
7. Chaparro-Huerta V., Beas-Zarate C., Guerrero M.U., Feria-Velasco A. Nitric oxide involvement in regulating the dopamine transport in the striatum of rat brain. Neurochem. Int. 31:1997;607-616.
8. Church W.H., Justice J.B. Jr., Byrd L.D. Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine. Eur. J. Pharmacol. 139:1987;345-348.
9. 3H ]haloperidol Life Sci. 17:1975;993-1002.
10. 11C ]WIN 35,428) J. Labeled Comp. Radiopharm. 20:1993;249-255.
11. 11C -raclopride and positron emission tomography J. Neurosci. 12:1992;3773-3780.
12. 11C -raclopride is altered by drugs that modify synaptic dopamine levels Synapse. 13:1993;350-356.
13. Dewey S.L., Smith G.S., Logan J., Simkowitz P., Brodie J.D., Volkow N.D., Fowler J.S., Wolf A.P. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography (PET) in normal human subjects. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11816-11820.
14. Dewey S.L., Smith G.S., Logan J., Alexoff D., Ding Y.-S., King P., Pappas N., Brodie J.D., Ashby C.R. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J. Neurosci. 15:1995;821-829.
15. 2-dopamine receptor binding in the living human brain by positron emission tomography. Science. 231:1986;258-260.
16. Fink-Jensen A., Ingwersen S.H., Nielsen P.G., Hansen L., Nielsen E.B., Hansen A.J. Halothane anesthesia enhances the effect of dopamine uptake inhibition on interstitial levels of striatal dopamine. Arch. Pharmacol. 350:1994;239-244.
17. 15O and positron emission tomography: theory, procedure and normal value J. Comput. Assist Tomogr. 4:1980;727-736.
18. Garthwaite J., Charles S.L., Cross-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 336:1988;385-388.
19. Giros B., Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., Caron M. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 3:1992;383-390.
20. Herscovitch P., Raichle M. What is the correct value for the brad-brain partition coefficient for water? J. Cereb. Blood Flow Metab. 5:1985;65-69.
21. Huang S.H., Barrio J., Phelps M. Neuroreceptor assay with positron emission tomography; equilibrium versus dynamic approach. J. Cereb. Blood Flow Metab. 6:1986;515-521.
22. 2 receptor in nonhuman primates Synapse. 10:1992;177-184.
23. 3H ]raclopride in reserpine-treated mouse brain J. Neural Transm. 85:1991;1-10.
24. 11C -raclopride against anesthetics in rhesus monkey brain J. Neural Transm. 100:1995;147-151.
25. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
26. Krebs M.O., Desce J.M., Kermel M.L., Gaucy C., Godeheu G., Cheramy A., Glowinski J. Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56:1991;81-85.
27. Kuczenski D., Segal D.S., Aizenstein M.L. Amphetamine, cocaine and fencamfamine: relationship between locomotor and stereotype response profiles and caudate and accumbens dopamine dynamics. J. Neurosci. 11:1991;2703-2712.
28. Kuhar M., Sanchez-Roa P., Wong D., Dannals R., Grigoriadis D., Lew R., Milberger M. Dopamine transporter: biochemistry, pharmacology and image. Eeu. Neurol. 30:1990;15-20.
29. Leviel V., Gobert A., Guibert B. The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function. Neuroscience. 39:1990;305-312.
30. Loeb A.L., Gonzales J.M., Reichard P.S. Isoflurane enhances glutamatergic agonist-stimulated nitric oxide synthesis in cultured neurons. Brain Res. 734:1996;295-300.
31. Maisonneuve I.M., Click S.D. Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior. Eur. J. Pharmacol. 212:1992;263-266.
32. Maisonneuve I.M., Ho A., Kreek K.J. Chronic administration of a cocaine "binge" alters basal extracellular levels in male rats: an in vivo microdialysis study. J. Pharmacol. Exp. Ther. 272:1995;652-657.
33. Maisonneuve I.M., Kreek M.J. Acute tolerance to the dopamine response induced by a "binge" pattern of cocaine administration in male rats: an in vivo microdialysis study. J. Pharmacol. Exp. Ther. 268:1994;916-921.
34. 15O and positron emission tomography J. Cereb. Blood Flow Metab. 7:1987;421-426.
35. 3H -GBR12935 J. Neural Transm. 87:1992;1-14.
36. Mintun M.A., Raichle M.E., Martin W.R.W., Herscovitch P. Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. J. Nucl. Med. 25:1984;177-187.
37. 11C -methylspiperone binding in vivo: positron emission tomography study using awake rhesus monkey Brain Res. 663:1994;191-198.
38. Opacka-Juffry J., Ahier R.G., Cremer J.E. Nomifensine-induced increase in extracellular striatal dopamine is enhanced by isoflurane anesthesia. Synapse. 7:1991;169-171.
39. Pettit H.O., Justice J.B. Dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psycopharmacology. 84:1984;167-173.
40. Phelps M.E., Huang S.C., Hoffman E.J., Kuhl D.E. Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin. J. Nucl. Med. 20:1979;328-334.
41. Reid M.S., Hsu K. Jr., Berger S.P. Cocaine and amphetamine preferentially stimulated glutamate release in the limbic system: studies on the involvement of dopamine. Synapse. 27:1997;95-105.
42. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transports are related to self-administration of cocaine. Science. 237:1987;1218-1223.
43. T.E. Robinson, Persistent sensitizing effects of drugs on brain dopamine systems and behavior: implications for addiction and relapse, in: S.G. Korenman, J.D. Barchas (Eds.), Biological Basis of Substance Abuse, Oxford Univ. Press, New York, 1993, pp. 373-402.
44. 3H ]WIN35,428 to central dopaminergic transporters Synapse. 23:1996;61-69.
45. 3H ]raclopride: implications for positron emission tomography of the human brain Synapse. 3:1989;96-97.
46. Shimada S., Kitayama S., Lin C., Patel A., Nauthakumar E., Grego P., Kuhar M., Uhl G. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science. 254:1991;576-578.
47. 11C -raclopride Soc. Neurosci. Abstr. 19:1993;128.
48. R. Snider, J.C. Lee, A Stereotaxic Atlas of the Monkey Brain (Macaca mulatta), Chicago Univ. Press, Chicago, 1961.
49. Sogaard U., Michalow J., Butler B., Lund-Laursen A., Ingersen S.H., Skrumsager B.K., Rafaelsen O.J. A tolerance study of single and multiple dosing of the selective dopamine uptake inhibitor GBR12909 in healthy subjects. Int. Clin. Psychopharm. 5:1990;237-251.
50. Takechi H., Onoe H., Imamura K., Onoe K., Kakiuchi T., Nishiyama S., Yoshikawa E., Mori S., Kosugi T., Okada H., Tsukada H., Watanabe Y. Brain activation study by use of positron emission tomography in unanesthetized monkey. Neurosci. Lett. 182:1994;279-282.
51. 2 receptors in the rat brain: an in vivo study using positron emission tomography. J. Neurosci. 16:1996;7670-7677.
52. Tsukada H., Lindner K.J., Hartvig P., Långström B. Effect of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the extracellular levels of dopamine and serotonin in the rat striatum: a microdialysis study with tyrosine or tryptophan infusion. Brain Res. 635:1994;59-67.
53. 11C ]raclopride?: PET studies combined with microdialysis in conscious monkeys Brain Res. 841:1999;160-169.
54. Volkow N.D., Fowler J.S., Gatley S.J., Logan J., Wang G.J., Ding Y.S., Dewey S. PET evaluation of the dopamine system of the human brain. J. Nucl. Med. 37:1996;1242-1256.
55. Watanabe M., Okada H., Shimizu K., Omura T., Yoshikawa E., Kosugi T., Mori S., Yamashita T. A high resolution animal PET scanner using compact PS-PMT detectors. IEEE Trans. Nucl. Sci. 44:1997;1277-1282.
56. 3H ]raclopride binding in the rat brain Synapse. 9:1991;188-194.